Elsa M. Hjerkinn

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine

Hilde Marie Angell Eid, Harald Arnesen, Elsa M. Hjerkinn et al. · Metabolism · 2004 · 140 citations

Obesity, Metabolic Syndrome, Metabolic Disorder +9

Influence of long-term intervention with dietary counseling, long-chain n−3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia

Elsa M. Hjerkinn, Ingebjørg Seljeflot, Ingrid Ellingsen et al. · American Journal of Clinical Nutrition · 2005 · 112 citations

Nutrition, Metabolic Syndrome, Cardiovascular Disease +6

A randomized clinical trial on<i>n</i>-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk

Gunnar Einvik, Tor Ole Klemsdal, Leiv Sandvik et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2010 · 92 citations · Full text

Effect of diet or very long chain  -3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia

Elsa M. Hjerkinn, Michael Abdelnoor, L. Breivik et al. · European Journal of Cardiovascular Prevention & Rehabilitation · 2006 · 91 citations · Full text